Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001663087 | SCV001872407 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
National Health Laboratory Service, |
RCV002225899 | SCV002504696 | likely benign | Hereditary breast ovarian cancer syndrome | 2022-04-19 | criteria provided, single submitter | clinical testing | |
Center for Genomic Medicine, |
RCV001694148 | SCV002760554 | benign | not specified | 2025-03-04 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001663087 | SCV005216412 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Clinical Genetics Laboratory, |
RCV001694148 | SCV001906362 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001694148 | SCV001952300 | benign | not specified | no assertion criteria provided | clinical testing | ||
Natera, |
RCV001827555 | SCV002080363 | benign | Ataxia-telangiectasia syndrome | 2019-10-17 | no assertion criteria provided | clinical testing |